Radioprotectants Targeting Thrombospondin-1 And Cd47

Patent No. EP2340034 (titled "Radioprotectants Targeting Thrombospondin-1 And Cd47") was filed by The United States OF America on Aug 5, 2009. The application was issued on Feb 13, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
WILDINGOct 27, 2016WILDING

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2340034

THE UNITED STATES OF AMERICA
Application Number
EP09791202A
Filing Date
Aug 5, 2009
Status
Patent Maintained As Amended
Jan 11, 2019
Publication Date
Feb 13, 2019